Institutional investors purchased a net $4.8 million shares of ANTH during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 47.60% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIAM LLC Bought 2.1 Million shares of Anthera Pharmaceuticals I...
SIO CAPITAL MANAGEMENT LLC Bought 617.9 Thousand shares of Anthera Pharmaceuticals I...